In SLE studies, CD74 was identified as a marker of exhausted regulatory CD4+T cell subset that contribute to SLE pathogenesis and showed therapeutic potential when blocked or knocked out in SLE animal models [10, 58, 59]. This evidence concerns the gene CD4 and systemic lupus erythematosus.